Pandemic flu fear propels vaccine sector

From the Globe and Mail:
From sleepy dowager a few years ago to high flier today, the vaccine industry is going full-out to expand manufacturing capacity to meet growing demand for flu shots and a possible pandemic.

In recent weeks, Novartis AG has bid $4.5-billion (U.S.) for the 58 per cent of drug and flu vaccine maker Chiron Corp. of Emeryville, Calif., that it doesn't already own, and GlaxoSmithKline PLC has agreed to acquire ID Biomedical Corp. of Vancouver for $1.4-billion. ...more